Neuroendocrine Carcinoma of Prostate
3 clinical trials · Condition
◉ Watch Neuroendocrine Carcinoma of Prostate
| Record | Firm | Date |
|---|---|---|
| A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate (NCT06941480) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients (NCT06893783) | Inkeun Park | 2025-09-02 |
| Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers (NCT05582031) | Translational Research in Oncology | 2023-04-30 |
Track Neuroendocrine Carcinoma of Prostate automatically
Every clearance here is in the API, with alerts when new ones post.